Bactericidal efficacy of tissue tolerable plasma on microrough titanium dental implants: An in-vitro-study

Saskia Preissner1, Henrik C Wirtz1, Anne-Kristin Tietz2

  • 1Department of Operative and Preventive Dentistry, Charité Universitätsmedizin Berlin, Aßmannshauser Str. 4-6, 14197, Berlin, Germany.

Journal of Biophotonics
|September 10, 2015
PubMed

Insights

Tissue tolerable plasma (TTP) effectively reduced Streptococcus mitis biofilms on titanium implants in vitro. This novel approach shows promise for peri-implant infection therapy, offering a potential alternative to conventional treatments.

Area of Science:

  • Biomedical Engineering
  • Microbiology
  • Dental Implantology

Background:

  • Peri-implant infections pose a significant challenge in dental implant therapy.
  • Current surface decontamination methods often have limitations in efficacy or biocompatibility.

Purpose of the Study:

  • To evaluate the bactericidal efficacy of tissue tolerable plasma (TTP) against Streptococcus mitis biofilms on titanium dental implants.
  • To compare TTP's effectiveness with a diode laser and a saline control.

Main Methods:

  • In vitro creation of S. mitis biofilms on microrough titanium implants.
  • Treatment groups included saline control, diode laser, and TTP (60s and 120s).
  • Bacterial load quantified by colony-forming units (CFU); biofilm structure and cell viability assessed via microscopy (CLSM, SEM, FM).

Main Results:

  • TTP significantly reduced CFU counts compared to the saline control (p < 0.05).
  • Logarithmic reduction factors for TTP were higher than for the diode laser.
  • Fluorescence microscopy indicated increased dead cell counts after TTP treatment.

Conclusions:

  • Tissue tolerable plasma demonstrates significant bactericidal efficacy against S. mitis biofilms on titanium implants.
  • TTP is a promising therapeutic option for peri-implant infections, irrespective of bacterial resistance.
  • Further clinical studies are warranted to explore TTP's impact in vivo.